eMedevents
  • 154,759+ Medical Conferences
  • 285 Specialties
  • 11,301 Organizers
  • 156,541 Speakers
  • 159 Countries
  • 4,789 Cities
51,586+
CME Conference Registrations Sold
Home  >  Speakers  >  Gregory Gregoriadis
Gregory Gregoriadis

Gregory Gregoriadis

    PhD, DSc
Founder, Professor | London, England    United Kingdom
Biochemistry And Molecular Genetics, Biotechnology,...More
Biotechnology, Clinical Pharmacology,...More

Biography :

Professor Gregory Gregoriadis is the Founder (1997) of Xenetic Biosciences Inc and creator of the company's polysialic acid and liposome technologies. He was a Board member, and CSO (1997-2015), Head of the Centre for Drug Delivery Research(1990-2001) at University College London, and Head of the Liposomes Group at the Medical Research Council (1972-1990). In 1971 he introduced (with B. Ryman) liposomes for drug and vaccine delivery and, in 1991, he introduced polysialic acid to improve the pharmacokinetics and pharmacodynamics of protein and peptide drugs.

**********************
** ** **** ****
 
For speaker's contact information - Contact us

Specialties

Biochemistry and Molecular Genetics, Biotechnology, Pharmacy and Medicine, Asthma Clinical Immunology, Clinical Pharmacology, Cell and Developmental Biology, Nanotechnology

Interested Topics

Biotechnology, Clinical Pharmacology, Nanotechnology, Pharmacy, Cell Biology, Asthma Clinical Immunology, Biochemistry and Molecular Genetics

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.

Appears with

  • This section has yet to be updated by the speaker.
Close

Send Message